Porcine xenografts transplanted into primates are rejected in spite of immunosuppression. Identification of the triggering mechanisms and the strategies to overcome them is crucial to achieve long-term graft survival. We hypothesized that porcine CD86 (pCD86) contributes to xenograft rejection by direct activation of host T cells and NK cells. Formerly, we designed the human chimeric molecule hCD152-hCD59 to block pCD86 in cis. To test the efficacy in vivo, we have utilized a pig-to-mouse xenotransplant model. First, we showed that hCD152-hCD59 expression prevents the binding of murine CD28Ig to pCD86 on porcine aortic endothelial cells (PAEC) and dramatically reduces IL-2 secretion by Con A-stimulated mouse splenocytes in coculture. Moreover, IFN-γ secretion by IL-12-stimulated mouse NK cells was averted after coculture with hCD152-hCD59 PAEC. In vivo, control PAEC implanted under the kidney capsule were rapidly rejected (2-4 weeks) in BALB/c and BALB/c SCID mice. Rejection of hCD152-hCD59 PAEC was significantly delayed in both cases. Signs of immune modulation in the hCD152-hCD59-PAEC BALB/c recipients were identified such as early hyporesponsiveness and diminished antibody response. Thus, simply modifying the donor xenogeneic cell can diminish both T cell and NK cell immune responses. We specifically demonstrate that pCD86 contributes to rejection of porcine xenografts. 75 76 COSTA ET AL.
INTRODUCTION
in proliferation and lymphokine secretion (29, 33) . The CD28 pathway provides costimulation not only to CD4 + There is no cure for many patients with diseases and T cells, but also to CD8 + and γ/δ T cells (29) . CD28 also injuries that lead to tissue loss or dysfunction (8). Likeparticipates in NK cell activation (29) . Therefore, the CD28wise, the number of organs available for allotransplanta-CD80/CD86 pathway is a key point for immune intertion does not suffice to meet the demand (2) . Research vention, particularly because CD28 signaling is cycloin xenotransplantation aims to provide a therapeutic sosporin A resistant (16) . CD152Ig has been the method lution, but progress in the field depends on overcoming of choice to block the CD28 pathway (29, 33) . Due to the immunological barriers. Delayed xenograft rejection the higher affinity of CD152 for CD80/CD86 relative to (DXR) and T-cell-mediated responses lead to porcine xeno-CD28 (29) , CD152Ig can act as a competitive inhibitor graft destruction in spite of immunosuppression (2, 8, 28) .
inducing T-cell anergy in vitro (33) . In vivo, CD152Ig A strong humoral response, type II endothelial activaled to indefinite graft survival and tolerance in some tion, and an acute cellular infiltrate containing NK cells models of allotransplantation (pancreatic islets), while in and macrophages lead to DXR of vascularized organs (2, others CD152Ig only prolonged engraftment (hearts) 28). Xenogeneic cells and tissues are also subjected to a (33) . Combining CD152Ig with other approaches such delayed rejection process (6). Both vascular and avascuas CD154 blockade induced allogeneic tolerance in lar xenografts are susceptible to cellular rejection in which highly stringent transplantation models (19, 33) . CD4 + T cells play a major role (2, 6) .
The CD28-CD80/CD86 costimulation pathway is pre-Ligation of CD28 by CD80/CD86 generates the stronserved in the pig-to-human xenogeneic combination. gest costimulatory signal for T-cell activation, resulting Porcine aortic endothelial cells (PAEC) provide strong costimulation to human T cells (7, 25, 27) and trigger hu-polybrene (Sigma, St. Louis, MO) method (32) and selected with 5 µg/ml puromycin (Sigma). Viral superna-man NK-cell-mediated cytotoxicity (5) through pCD86. This effect is resistant to calcineurin inhibitors (7) . Len-tants were subsequently harvested to infect 5 × 10 5 PAEC (Cell Systems, Kirkland, WA). Two days later, schow et al. (23) were first to demonstrate that systemic treatment with CD152Ig induces donor-specific tolerance PAEC underwent drug selection in DMEM (Mediatech Inc., Herndon, VA)/10% FCS (Hyclone, Logan, UT) in a xenogeneic setting (human pancreatic islets grafted in mice). However, further studies proved the difficulty containing 3 µg/ml puromycin. Drug-resistant cell populations were identified by flow cytometry using antibod-of achieving long-term graft acceptance with CD152Ig alone despite some efficacy in prolonging survival of ies specific to hCD152 and hCD59. concordant xenografts (9,21). The need for combination
Flow Cytometry therapies such as CD152Ig with CD154 blockade to achieve Immunofluorescence of hCD152, pCD86, and SLAI indefinite survival of pig and rat pancreatic islets in mice was performed with monoclonal antibodies BNI3 reflects the higher requirements of most xenografts for (Immunotech, Marseille, France), 10B11.34 (Alexion tolerance induction relative to allografts (22, 33) . More-Pharmaceuticals, Cheshire, CT), and PT85A (VMRD, over, blockade of the CD28 and CD40 pathways only Pullman, WA), respectively. Goat anti-mouse Ig FITCconfers partial protection, delaying but not preventing conjugated antiserum (Zymed Laboratories, Inc., San rejection of concordant xenogeneic hearts (9,22). None Francisco, CA) was used to detect specific reactivity. of these in vivo studies explored the contribution of The binding of murine CD28 (mCD28) to pCD86 was CD28 on NK cells to xenograft rejection. Moreover, the assessed using a fusion protein containing the extracelludistinct roles of donor and recipient CD80/CD86 were lar domain of mCD28 and the Fc portion of human IgG1 not determined. Human CD152 (hCD152) binds CD80/ (kindly provided by Dr. Yang Liu, Ohio State Univer-CD86 of various species (23, 27) . In addition, CD152Ig sity, OH). Goat anti-human IgG FITC-conjugated antiand specific antidonor CD80/CD86 antibodies could trigserum (Zymed Laboratories) was used as secondary ger complement activation and antibody-dependent cellantibody. The analysis was conducted with a BD Bioscimediated cytotoxicity through the Fc portion. Our group ences FACSort (San Jose, CA). has designed a general strategy based on modifying the donor xenogeneic cell to render it less immunogenic (4, Coculture Assays 11). Accordingly, we have expressed on porcine cells a hCD152-hCD59 chimeric molecule that functions in cis T-cell activation by PAEC was assayed using a modified costimulation assay (25) . PAEC were seeded to con-to prevent the activation of human T cells (27) and NK cells mediated by pCD86 (CD80 was not detected on fluency in a 96-well cluster 24 h prior to coculturing. Spleen cells were isolated from BALB/c mice in DPBS/ these cells) (5). Expression of hCD152-hCD59 is directed to the cell surface where the molecule hCD59 1% FCS after mechanical disruption and one-step ACK lysis (Biofluids, Rockville, MD) and added at a 2:1 ratio is anchored by the glycosyl-phosphatidylinositol linkage (27) . The chimeric molecule is flexible enough to allow in complete medium (21) . Mouse anti-hCD152 (10 µg/ ml, Ancell Corporation, Bayport, MN) and porcine the hCD152 portion to bind pCD86 on the same cell, thereby preventing CD28 and antibody accessibility (5, CD152Ig (pCD152Ig, 5 µg/well, Alexion Pharmaceuticals) were added when indicated. Concanavalin A (10 27). To test the efficacy of this approach in vivo, we have developed a small-animal cell transplantation model µg/ml, Sigma) was added 30 min later. After 22 h of coculture at 37°C, cell-free supernatants were collected using vector-control or hCD152-hCD59-expressing PAEC implanted under the kidney capsule of BALB/c or BALB/c and assayed undiluted for mouse IL-2 by ELISA (R&D Systems, Minneapolis, MN). Plates were read on a micro-SCID mice. In this highly stringent discordant system, we show that expression of hCD152-hCD59 on porcine plate reader 3550 (Biorad, Hercules, CA) at 450 nm. NK cell activation by PAEC was assayed using a cells significantly delays xenograft rejection by inhibiting both T-cell and NK-cell immune responses.
modified coculture experiment (10). PAEC were seeded to confluency in a 96-well cluster 24 h prior to cocultur-MATERIALS AND METHODS ing. Mouse NK cells were isolated from BALB/c SCID Genetic Engineering of Porcine Aortic mice in complete medium as described (10). Briefly, Endothelial Cells each SCID spleen was dissociated and the splenocytes plated in a T25 flask for 2 h at 37°C to remove macro-The hCD152-hCD59-expressing PAEC were generated by retroviral transduction (27) . To produce viruses, phages. The nonadherent cell preparations were pooled from three to four mice and added to confluent PAEC the murine amphitropic packaging cell line PA317 (ATCC, Rockville, MD) was transfected with BABEpuro-hCD152-at the indicated effector/target ratios. PMA (10 ng/ml, Sigma), mouse IL-12 (5 ng/ml, Biosource International hCD59, or BABEpuro vector-control DNA (24) by the Inc., Camarillo, CA), and anti-mCD28 antibody 37.51 were counted in a hemocytometer and subsequently stained with specific anti-mouse CD4-FITC, CD8-FITC, (5 µg/ml, BD PharMingen, San Diego, CA) were also added when indicated. Cell-free supernatants were col-and CD19-FITC antibodies (BD PharMingen). CD4-FITC and CD8-FITC staining was also carried out in lected 20 h later and assayed undiluted for mouse IFN-γ by ELISA (R&D Systems). The percentage of NK cells combination with a PE-conjugated anti-mouse CD25 (BD PharMingen) for double-color analysis. Cell surface was determined for each assay by flow cytometry with FITC-conjugated DX5 antibody (BD PharMingen) and staining of a gated population of lymphocytes was then measured by FACS. PE-conjugated anti-mCD28 antibody (BD PharMingen). The pooled cell preparations contained 50-70% NK
Statistical Analysis cells with the majority of NK cells expressing moderate
Values are expressed as mean ± SE. Statistical analylevels of CD28. In all cases the DX5-negative cells sis was carried out using the Student t-test. Differences showed no CD28 expression.
were considered statistically significant at p ≤ 0.05.
Transplant Studies
RESULTS We used 6-8-week-old BALB/c or BALB/c SCID Expression In Cis of hCD152-hCD59 Blocks mice from The Jackson Laboratories (Bar Harbor, ME).
pCD86 Binding to mCD28 and Inhibits T-Cell PAEC were isolated, in some experiments prelabeled and NK-Cell Activation with 25 µM CFSE (Molecular Probes, Eugene, OR) for 15 min at 37°C, and stored on ice until transplantation.
It is unclear whether murine T cells and NK cells can A pellet of 5 × 10 6 cells was mixed with about 30 µl of be directly activated by pCD86. Prior to using a mouse syngeneic blood to clot and surgically implanted under model to assess the effect of pCD86 blockade on xenothe left kidney capsule. Mice were monitored until the graft rejection, we tested the binding of mCD28Ig to harvest time.
control or hCD152-hCD59-expressing PAEC. First, we demonstrated that hCD152-hCD59-transduced PAEC (27) Histologic Analyses expressed high levels of hCD152-hCD59 and showed a The grafted kidneys were retrieved and sectioned in 90% reduction in anti-pCD86 antibody reactivity comtwo portions, both containing the implant. One portion pared with vector control cells ( Fig. 1 ). Expression of was formalin fixed and embedded in paraffin. The other CD80 was not detected on these cells (data not shown). portion was embedded and frozen in Tissue-Tek OCT No difference in SLAI expression was detected between compound (Sakura Finetek USA, Torrance, CA). Frozen the two transductants. The binding of mCD28Ig to sections with CFDA-labeled cell grafts were directly ex-pCD86 was demonstrated by flow cytometry in control amined under a fluorescence microscope. Paraffin sec-PAEC ( Fig. 1 ). This interaction was solely mediated by tions (4 µm) were stained with hematoxylin and eosin pCD86, as mCD28Ig binding was abrogated when con-(H&E) and evaluated independently by two investigatrol cells were preincubated with an anti-pCD86 blocktors. To cover all the grafted area, we examined 6-12 ing antibody (data not shown). Moreover, mCD28Ig sections from each grafted kidney collected every 10-15 reactivity to hCD152-hCD59-expressing PAEC was sections (assessing 360-480 µm total) at 200× magnifinegligible ( Fig. 1 ). cation. Two sets of scores were implemented to describe
To study the mouse anti-pig immune responses, we the degree of rejection: the amount and pattern of leukoutilized an in vitro assay to test T-cell activation (IL-2 cytic infiltrate and the relative graft size. secretion) stimulated by vector-control or hCD152-hCD59engineered PAEC ( Fig. 2A ). We cocultured naive BALB/ Detection of Anti-PAEC Antibodies c splenocytes and vector-control or hCD152-hCD59-PAEC were incubated for 30 min at 4°C with 10%, transduced PAEC with or without Con A. No IL-2 was 1%, or 0.1% heat-inactivated serum. FITC-conjugated goat detected when splenocytes were cultured with vectoranti-mouse IgG and IgM were used as secondary anticontrol PAEC in the absence of Con A ( Fig. 2A ). Howbodies (Zymed Laboratories) in one set of experiments. ever, Con A-stimulated splenocytes cocultured with vec-The different IgG isotypes were similarly detected using tor-control PAEC secreted 298 pg/ml of IL-2 ( Fig. 2A ). anti-mouse IgG1, IgG2a, IgG2b, and IgG3 antibodies
The addition of anti-hCD152 had no effect on costimu-(BD Biosciences, San Diego, CA). The mean fluoreslation by vector-control PAEC, whereas pCD152Ig cence intensity was measured by FACS.
caused a dramatic reduction in IL-2 secretion. Moreover, only 86 pg/ml of IL-2 was detected when Con A-stimu-Analysis of Lymphocytes lated splenocytes were incubated with hCD152-hCD59 PAEC ( Fig. 2A) . The anti-hCD152 antibody counter-Lymphocytes were isolated in DPBS/1% FCS after mechanical disruption of the mesenteric lymph nodes. Cells acted this reduction, restoring IL-2 secretion, and pCD152Ig enhanced the costimulatory blockade in Xenograft Rejection Is Delayed in Mice Receiving hCD152-hCD59-Expressing PAEC hCD152-hCD59-PAEC cocultures ( Fig. 2A) .
We studied the effect of pCD86 blockade on NK-cell To test the efficacy of hCD152-hCD59 in vivo, we activation using a similar coculture assay in which we transplanted vector-control or hCD152-hCD59 PAEC determined IFN-γ secretion (Fig. 2B ). IFN-γ was below under the kidney capsule of BALB/c mice without imdetectable levels in the absence of any additional stimumunosuppression ( Fig. 3 ). Grafted kidneys were collation. When murine IL-12 was added to the vector-conlected at 2, 3, and 5 weeks posttransplantation to evalutrol PAEC cocultures, it markedly augmented IFN-γ ate the degree of rejection. At 2 weeks the graft was secretion in a manner that correlated with the effector/ detected in both groups, although the graft size was target (E:T) ratio (Fig. 2B) . In contrast, secretion of larger in the hCD152-hCD59-PAEC cohort (Fig. 3A, B ).
IFN-γ was negligible when NK cells were cocultured
Moreover, we observed a pronounced mononuclear cell with hCD152-hCD59 PAEC (Fig. 2B ). To further stimuinfiltrate in the vector-control-PAEC grafts (Fig. 3A ), late the system, a combination of IL-12 and PMA was while only minor focal areas of infiltrate were detected added to the cocultures. Whereas PMA alone did not in the hCD152-hCD59-PAEC grafts (Fig. 3B ). This imactivate NK cells to secrete IFN-γ, when combined with mune infiltrate was shown to contain T cells by immu-IL-12 and vector-control PAEC led to very high IFN-γ nofluorescence in both cohorts (data not shown). The secretion (705 pg/ml at 10:1 E/T ratio) ( Fig. 2B ). As a relative degree of rejection between the two groups was control, we used NK cells cultured alone with PMA and consistent at 3 weeks posttransplantation in regard to the IL-12 (567 pg/ml). Addition of an activating anti-CD28 amount of cellular infiltrate (Fig. 3C, D) . However, the antibody to this combination further increased IFN-γ segraft size was reduced for both cohorts (Fig. 3C, D) . To cretion (953 pg/ml). On the contrary, coculture with better appreciate the differential effect between hCD152-hCD152-hCD59 PAEC led to very low IFN-γ secretion hCD59 and vector-control PAEC, we scored each graft (80% reduction at 10:1 and 5:1 E/T ratio) or no secretion sample from 0 to 4, evaluating the cellular infiltrate and (1:1 E/T ratio) (Fig. 2B) .
the graft size, and calculated the mean ± SE (Fig. 3E , Cell supernatants were assayed for IL-2 by ELISA. The bar graph depicts the concentration of IL-2 found as a result of cocultures containing no Con A, Con A, Con A with anti-hCD152 antibody, and Con A with soluble pCD152Ig. Results are shown as mean ± SE corresponding to splenocytes from six naive BALB/c mice (each isolate assayed separately in two experiments with n = 3 each). Significant differences were detected between V-PAEC and CC-PAEC incubated with Con A as indicated, **p ≤ 0.005. The reduction in IL-2 secretion caused by pCD152Ig in V-PAEC was also significantly different from the Con A control (p = 0.0033). (B) NK-cell activation by V-PAEC and CC-PAEC was assessed in coculture experiments with splenocytes isolated from BALB/c SCID mice. Cell supernatants were assayed for IFN-γ by ELISA. The bar graph depicts the concentration of IFN-γ found as a result of cocultures at the indicated effector/target ratios in the presence or absence of PMA (right and left panel, respectively) and IL-12.
Results are shown as mean ± SE of triplicate cocultures and are representative of three independent experiments. Significant differences were detected between cocultures with V-PAEC or CC-PAEC at all effector/target ratios assayed, **p ≤ 0.005. F). The amount of cellular infiltrate was significantly munocompetent BALB/c mice. It contained mostly lymphocytes that we assumed to be NK cells because these reduced in the hCD152-hCD59 PAEC versus the vectorcontrol PAEC recipients at 2 and 3 weeks posttransplan-mice lack T cells (determined by flow cytometry of splenocytes and tissue immunofluorescence) (data not shown). tation (Fig. 3E) . Consistently, the overall size of the hCD152-hCD59-PAEC grafts was larger relative to the In this setting, we were able to detect a reduction in the amount of cellular infiltrate in the hCD152-hCD59-controls at 2 and 3 weeks ( Fig. 3F ). By 5 weeks posttransplantation both groups had lost the graft. Results PAEC recipients compared with controls at 2 and 3 weeks posttransplantation (Fig. 4A ). Most importantly, with CFSE-labeled PAEC correlated with these H&E findings (data not shown).
the graft size was much larger in the hCD152-hCD59 experimental group at 3 and 5 weeks (Fig. 4B ). The con-Following the same scoring system, we evaluated the effect of expressing hCD152-hCD59 in PAEC trans-trol PAEC implant was already rejected by week 5 (Fig.  4A, B) . The transplanted control PAEC were so scarce planted into SCID mice (Fig. 4A, B) . As expected, the mononuclear cell infiltrate was overall lower than in im-at 3 weeks posttransplantation that we used the CFSE Results are shown as mean ± SE corresponding to five SCID mice in each group with the exception of the 2-week V-PAEC recipients with n = 6. We used the same criteria described in Figure 2 legend. Significant differences were detected between V-PAEC and CC-PAEC recipient cohorts in each time point as indicated, *p ≤ 0.05, **p ≤ 0.005. Tissue sections of SCID kidneys grafted with CFSE-prelabeled PAEC were also examined under the fluorescence microscope. V-PAEC (C, E) and CC-PAEC (D, F) grafts were evaluated at 3 weeks (C, D) and 5 weeks posttransplantation (E, F). Note all grafts were located above the kidney parenchyma, which shows high autofluorescence. The original magnification was ×200 (C-F).
labeling system to confirm our H&E observations. We reactivity to PAEC ( Figs. 5 and 6 ). An elevation in anti-PAEC antibody titers was readily seen at 2 weeks post-detected a few CFSE-labeled cells in the control-PAEC cohort at 3 weeks, but not at 5 weeks posttransplantation transplantation in grafted mice (Fig. 5A, B ). In the case of mice transplanted with hCD152-hCD59 PAEC, both (Fig. 4C, E) . Cells were readily observed at both time points in the hCD152-hCD59-PAEC recipients (Fig. 4D , IgM and IgG titers reactive to PAEC were significantly lower compared with control graft recipients (Fig. 5A,  F) . However, we noted a reduction in the graft size relative to earlier time points and observed active giant cells B). Differences between the two grafted groups were not as pronounced for the IgM subtype (26% reduction, Fig.  and macrophages in the area (data not shown) .
5A) as for total IgG (43% reduction, Fig. 5B ). More-The Humoral Response Is Diminished in BALB/c Mice over, there were also differences between the various Receiving hCD152-hCD59-Expressing PAEC IgG isotypes. The control PAEC recipients had high IgG1 titers relative to the other isotypes ( Fig. 5C ), inter-We determined anti-PAEC antibody reactivity in semediate IgG2a and IgG3 titers, and low IgG2b reactivity rum from mice transplanted with control or hCD152-( Fig. 5D-F) . Serum IgG1 levels were reduced as much hCD59 PAEC by FACS (Fig. 5 ). Results are presented as 67% in the hCD152-hCD59 PAEC recipients relative using 1% serum as it showed a linear correlation beto transplanted controls (Fig. 5C ), whereas IgG2a and tween antibody reactivity and titer. Sera from nontrans-IgG3 were approximately 50% lower (Fig. 5D, E) . We planted mice had very low IgM and no IgG antibody observed the most striking difference in the IgG2b titers detected no significant differences in IgG1, IgG2a, or IgG3 titers between the two transplanted groups (Fig.  (69% lower, Fig. 5F ).
The anti-PAEC antibody response was also moni-6C, D, F). Only the IgG2b titers were significantly higher in the hCD152-hCD59-grafted cohort compared with tored in recipients of vector-control or hCD152-hCD59 PAEC at the 3-week time point (Fig. 6 ). This experiment control recipients, although the overall reactivity was low (Fig. 6F) . was conducted separately from the 2-week assay and therefore a direct comparison cannot be made due to inter-
The Cellular Response Is Reduced in BALB/c Mice assay variability (Figs. 5 and 6 ). However, we tested a
Receiving hCD152-hCD59-Expressing PAEC few serum samples simultaneously, which suggested the IgM response was waning at 3 weeks while total IgG
We analyzed lymphocytes from the mesenteric lymph nodes to assess the cellular response. The total number titers were unchanged or slightly lower in the control transplant group (data not shown). At 3 weeks posttrans-of lymphocytes was increased about 2.5-fold in the vector-control PAEC recipients at 2 weeks posttransplanta-plantation, anti-PAEC IgM titers were comparable between the two grafted cohorts (Fig. 6A) . Moreover, we tion relative to naive mice (41.6 ± 6.6 vs. 16.2 ± 1.3 million cells, respectively). In contrast, mice grafted with observed no significant differences in total IgG titers reactive to PAEC between the hCD152-hCD59 PAEC and hCD152-hCD59 PAEC showed numbers similar to unprimed mice at this time point (16.9 ± 1.9 million). A vector-control PAEC recipients at this time point (Fig.  6B ). We also determined the various IgG isotypes and less dramatic reduction was observed at 3 weeks post- transplantation (23 ± 7 vs. 36.7 ± 7.2 million cells in the control transplant group). The proportion of CD4 + , CD8 + , and CD19 + cells was similar for the two transplanted cohorts at the 2-week time point (data not shown). However, we detected a small but significant increase in the percentage of CD25 + cells within the CD4 + population in the hCD152-hCD59 PAEC recipients (20.3 ± 0.5% vs. 17.5 ± 0.6% in the control grafted group).
To understand the initial T-cell activation events, we repeated the transplant experiment to harvest lymphocytes and splenocytes at 1 week posttransplantation. The number of lymphocytes isolated from the mesenteric lymph nodes was similarly elevated in the two transplanted cohorts (30.9 ± 6.5 million cells for controls and 31.1 ± 4.6 million cells for the hCD152-hCD59 PAEC recipients). We observed no difference in the proportion of T cells or in the CD25 + population. On the contrary, the in vitro costimulation assay testing T-cell activation by PAEC showed diminished IL-2 secretion overall when using splenocytes from hCD152-hCD59 PAEC recipients (Fig. 7B ) relative to controls (Fig. 7A ). We controlled for nonspecific activation due to isolation problems by processing all the samples equally and by assaying simultaneously three samples from each group (naive, vector-control, and hCD152-hCD59-PAEC primed) in two independent experiments. Interestingly, unlike naive splenocytes ( Fig. 2A) , spleen cells harvested 1 week posttransplantation were readily activated and secreted IL-2 in PAEC cocultures without Con A (Fig. 7A, B ). ). We noted the greatest reduction in IL-2 secretion picts the concentration of IL-2 found as a result of cocultures when splenocytes from hCD152-hCD59-PAEC-primed containing no Con A, Con A, Con A with anti-hCD152 antimice were cocultured with hCD152-hCD59 PAEC body, and Con A with soluble pCD152Ig. Results are shown ( Fig. 7B ).
as mean ± SE corresponding to splenocytes from six BALB/c mice (each isolate assayed separately in two experiments with n = 3 each). Significant differences were detected between V-
DISCUSSION PAEC and CC-PAEC incubated with Con A, as well as with
Under conditions of immunosuppression that allow humoral and cellular mechanisms (2, 28) . Unlike many human cells, porcine cells express CD86 in a constitutive manner and activate human T and NK cells through demonstrated by a marked reduction in IL-2 secretion when Con A-stimulated mouse splenocytes were cocul-the CD28 pathway (coculture studies) (5, 7, 25, 27) . Our results point to a relevant contribution of donor pCD86 tured with hCD152-hCD59 PAEC. In vivo, hCD152-hCD59 PAEC showed enhanced survival in the absence to xenograft rejection by direct activation of host T cells and NK cells in vivo. We previously showed that hCD152-of any immunosuppression relative to controls in BALB/c recipients, consistent with a blockade of the direct path-hCD59 expressed on porcine cells inhibits pCD86-mediated activation of human T and NK cells (5, 27) . We have way of rejection (2) . In this mouse model, the presence of hCD59 in our chimeric molecule is irrelevant because now developed a pig-to-mouse xenotransplant model to test this approach in a preclinical study. The binding of it does not inhibit mouse complement (30). Despite the controversy over the existence of the direct pathway in mCD28Ig to pCD86 indicated the potential for porcine cells to costimulate mouse T cells directly, which was the pig-to-mouse xenotransplant setting (failure of mouse purified T cells to respond to PAEC), a direct T-cell BALB/c recipients displayed a predominant Th2 response with high IgG1 titers. Moreover, pCD86 block-response was demonstrated in a pig-to-mouse (II-4 + mouse) skin graft model (3) . The contribution of donor ade by hCD152-hCD59 expression was accompanied by a marked reduction in anti-PAEC IgG1 production at CD80 to the xenogeneic direct response was shown after transplanting human pancreatic islets in mice using an 2 weeks posttransplantation. This reduction was more dramatic than that of anti-PAEC IgG2a and IgG3 com-anti-human CD80 antibody (CD80 expression was restricted to carrier donor leukocytes) (23) . Another study bined, thus shifting the antibody response toward a Th1 response (IgG1/IgG2a + IgG3 ratios of 2.1 and 1.3 for failed to demonstrate a role of donor CD80/CD86 in a concordant rat-to-mouse cardiac xenograft model (17), vector-control and hCD152-hCD59-PAEC cohorts, respectively). In xenotransplantation, Th1 immune deviation but the use of whole antibodies may have masked the effect. Our results reinforce the idea that the direct path-may be advantageous by promoting xenograft survival and resistance to DXR (36) . In particular, a reduction way contributes to xenograft rejection and specifically demonstrate a role of donor pCD86.
in the xenoantibody response may have contributed to prolong survival of grafted hCD152-hCD59 PAEC. Our Previous work has overlooked the role of donor costimulatory molecules in NK cell responses following trans-results agree with a major role for the CD80/CD86-CD28 pathway in generating an antibody response, spe-plantation. To elucidate the contribution of donor CD86 to NK-cell-mediated rejection, we conducted in vitro cifically the IgG1 and IgG2b isotypes (18) . Moreover, it may reflect a more relevant role of mouse CD152 pro-and in vivo studies. A critical role for pCD86 in NKcell activation was demonstrated when IFN-γ secretion moting a Th1 response in this setting (34) . Activated T cells may bind residual pCD86 on hCD152-hCD59 by mouse NK cells was averted in hCD152-hCD59 PAEC cocultures in the presence of IL-12. Moreover, we ob-PAEC through CD152 instead of CD28. We have detected hCD152Ig reactivity on hCD152-hCD59 PAEC served enhanced survival of hCD152-hCD59-expressing PAEC relative to controls in SCID mice up to 5 weeks by FACS (data not shown). A key role of CD152 engagement in the induction of tolerance to antigens and posttransplantation. Although there are no available antibodies to detect NK cells in tissue sections of BALB/c allografts has been described (26) . Moreover, targeting only the donor CD86 preserves the indirect pathway, and BALB/c SCID mice, the only cell population positive for CD28 in these SCID mice corresponded to NK which is necessary to achieve long-term allograft survival and the generation of regulatory T cells after costi-cells (assessed by flow cytometry of splenocytes). Thus, our results indicated that NK cells were involved in the mulatory blockade (37). Evidence exists for different mechanisms of tolerance process of PAEC rejection through the CD28 receptor. The exact contribution of this pathway to xenograft re-induction by inhibiting the CD28 pathway, including anergy, deletion of antigen-reactive cells, and induction of jection in the fully immunocompetent mouse needs further investigation, but recent studies describe an intricate regulatory T cells (33) . All these mechanisms may contribute to prolong xenograft survival. We observed some relationship between different cell types involved in innate and adaptive immunity. NK cells and dendritic cells component of all three features of tolerance induction in the hCD152-hCD59-PAEC recipients. We detected a trend (DC) activate each other through cell contact and cytokine secretion, resulting in increased DC-mediated stim-toward hyporesponsiveness 1 week after hCD152-hCD59-PAEC grafting, as determined by splenocyte PAEC co-ulation of CD4 + T cells (10,12). Transplanted PAEC may also play a role in this cross-talk by directly stimulating culture experiments. At 1 week posttransplantation, the two transplanted cohorts showed similar quantity and NK cells, which in turn activate the PAEC, resulting in enhanced T cell direct recognition (13). In addition, NK-phenotype of lymphocytes isolated from mesenteric lymph nodes. In contrast, lymphocyte counts were re-cell-mediated antibody production leads to increased IgG2b titers in mice (35) . Interestingly, the most dramatic duced at 2 and 3 weeks posttransplantation in the hCD152-hCD59-PAEC graft recipients, suggesting a de-reduction in anti-pig antibody titers in the hCD152-hCD59 PAEC recipients was observed for the IgG2b letion mechanism. Finally, we observed higher IgG2b titers at 3 weeks posttransplantation in the hCD152-isotype and suggests a role for CD86-mediated NK-cell activation during xenograft rejection.
hCD59-PAEC-grafted cohort relative to the control. IgG2b titers are heightened by TGF-β (15), which is The importance of the CD28 pathway in xenograft rejection is supported by numerous studies (21-23, known to have potent immunosuppressive properties. Although we have not investigated the direct involve-25,27), whereas the CD40-CD154 pathway appears to be of secondary importance (20, 38) . The characteristic ment of TGF-β, it is possible that regulatory T cells secreting TGF-β caused this increase in IgG2b titers (1). Th2 response induced by xenografts (2, 36) is in accordance with CD28 promoting Th2 differentiation (31) .
The elevation in CD4 + CD25 + T cells in the hCD152-hCD59-PAEC-grafted mice further suggests the involve-Consistent with previous studies (36), the control-PAEC
